Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
2,371,778
-
Number of holders
-
8
-
Total 13F shares, excl. options
-
140,823
-
Shares change
-
+140,823
-
Total reported value, excl. options
-
$1,145,879
-
Value change
-
+$1,145,879
-
Number of buys
-
8
-
Price
-
$8.14
Institutional Holders of Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) as of Q4 2024
As of 31 Dec 2024 Ensysce Biosciences, Inc. - Common Stock, par value $0.0001 per share (ENSC) had 8 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 140,823 shares of stock of the company.
Largest 8 holders included PERCEPTIVE ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., FNY Investment Advisers, LLC, UBS Group AG, Tower Research Capital LLC (TRC), BlackRock, Inc., MORGAN STANLEY, and BANK OF AMERICA CORP /DE/.
This table shows 8 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.